C4 Therapeutics, Inc. (CCCC) vs Fennec Pharmaceuticals Inc. (FENC)
A side-by-side comparison of C4 Therapeutics, Inc. and Fennec Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CCCC
C4 Therapeutics, Inc.
$2.84HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
FENC
Fennec Pharmaceuticals Inc.
$10.24HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — CCCC vs FENC
growth of $100 · dividends reinvested · last 6yCCCC -88.3% (-30.0%/yr)FENC +75.2% (+9.8%/yr)FENC compounded faster over this window
Log scale — wide-divergence pair
CCCC FENC
CCCC vs FENC: by the numbers
- •FENC is the larger company ($356M vs $313M market cap).
- •Both run net losses; FENC's is the smaller (-5.49% vs -289.44% net margin).
- •FENC grew revenue faster over the past five years (222.46% vs 0.65% CAGR).
Metrics side by side
Valuation
| Metric | CCCC | FENC |
|---|---|---|
| Forward P/E | N/A | 36.14 |
| P/S ratio | 8.95 | 6.01 |
| P/B ratio | 1.27 | 8.38 |
Profitability
| Metric | CCCC | FENC |
|---|---|---|
| Gross margin | 77.81% | 93.73% |
| Operating margin | -290.68% | -14.22% |
| Net margin | -289.44% | -5.49% |
| ROE | -41.02% | -7.66% |
| ROIC | -35.92% | -1.84% |
Growth (annualized)
| Metric | CCCC | FENC |
|---|---|---|
| Revenue CAGR (5Y) | 0.65% | 222.46% |
| Total return CAGR (5Y) | -41.77% | 2.45% |
Frequently asked
- Which has grown faster, CCCC or FENC?
- Over the past five years, FENC grew revenue faster — CCCC at a 0.65% CAGR versus FENC at 222.46%.
- How have CCCC and FENC total returns compared?
- Over the past 5 years, CCCC delivered -41.77% and FENC delivered 2.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
C4 Therapeutics ROEFennec Pharmaceuticals ROEC4 Therapeutics operating marginFennec Pharmaceuticals operating marginC4 Therapeutics revenue growthFennec Pharmaceuticals revenue growthC4 Therapeutics free cash flowFennec Pharmaceuticals free cash flow
C4 Therapeutics & Fennec Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.